Stockscreener 앱 받기
57.31
0.36%
-0.17
Bristol Myers Squibb Co 주식(BMY)의 최신 뉴스
Bristol Myers (BMY) Partnership Enhances Oxford Biomedica's Outl - GuruFocus
AI ECGs found 11 hidden heart disease cases and brought patients back to care - Stock Titan
Bristol Myers (BMY) Unveils New Data at 2026 ACC Conference - GuruFocus
insitro expands Bristol Myers Squibb ALS collaboration - Investing.com
AI drug discovery deal widens as Bristol Myers adds 2 ALS targets - Stock Titan
Wealth Enhancement Advisory Services LLC Purchases 318,898 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
TABR Capital Management LLC Invests $1.62 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers heart drug shows Phase 3 benefit in adolescents with oHCM - Stock Titan
Bristol Myers wins FDA approval for Opdivo in first-line Hodgkin lymphoma - MSN
Bristol Myers Squibb Co. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
NorthCrest Asset Manangement LLC Purchases 36,677 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb: A Defensive Dividend Stock for Volatile MarketsNews and Statistics - IndexBox
A Look At Bristol Myers Squibb (BMY) Valuation As Recent Results Shape Growth And Cost Outlook - simplywall.st
IAM Advisory LLC Takes $1.66 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
20,156 Shares in Bristol Myers Squibb Company $BMY Purchased by MFG Wealth Management Inc. - MarketBeat
CWA Asset Management Group LLC Sells 35,291 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb stock faces pressure after earnings miss and cautious FY2026 guidance amid pipe - AD HOC NEWS
Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. - PharmiWeb.com
Bristol Myers (BMY): New Approvals for Opdivo Expand Treatment O - GuruFocus
Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab) - Business Wire
Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch
Bristol Myers Squibb (BMY) Gains FDA Approval for Expanded Use o - GuruFocus
Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma - Benzinga
Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma - Benzinga
Bristol Myers wins FDA label expansion for Opdivo (BMY:NYSE) - Seeking Alpha
US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma - Reuters
Here is what to know beyond why Bristol Myers Squibb Company (BMY) is a trending stock - MSN
Top Stock Picks of 2026: Bristol-Myers Squibb - Schaeffer's Investment Research
CIBC Bancorp USA Inc. Makes New Investment in Bristol Myers Squibb Company $BMY - MarketBeat
BMY Technical Analysis | Trend, Signals & Chart Patterns | BRISTOL-MYERS SQUIBB CO (NYSE:BMY) - ChartMill
Bristol Myers Squibb Kidney Cancer Trial Tests Valuation And Pipeline Depth - simplywall.st
Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors - MarketWatch
Swiss Life Asset Management Ltd Purchases 68,565 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Wilmington Savings Fund Society FSB Has $5.24 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026 - The Joplin Globe
Bristol-Myers Squibb Co Stock (ISIN: US1101221083) Faces Mixed Signals After Q4 Earnings Miss Amid S - AD HOC NEWS
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation - Eagle-Tribune
BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncologists - Fierce Pharma
Merck vs. Bristol Myers: Which pharma stock is a better pick in 2026? - MSN
WBI Investments LLC Has $2.70 Million Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
US FDA approves J&J's oral psoriasis pill - Reuters
Danske Bank A S Makes New $71.59 Million Investment in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Stake Boosted by Achmea Investment Management B.V. - MarketBeat
Physician Views Preview: Can BMS' Sotyktu provide a new oral standard of care for psoriatic arthritis? - FirstWord Pharma
Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study - TipRanks
Jefferies raises Bristol-Myers Squibb stock price target on trial data - Investing.com India
Jefferies raises Bristol-Myers Squibb stock price target on trial data By Investing.com - Investing.com South Africa
Can Bristol Myers Squibb’s pipeline strategy offset a major patent cliff? - Labiotech.eu
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock - Yahoo Finance
HSBC Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $60 - 富途牛牛
Bristol Myers Squibb Company $BMY Stock Position Increased by Gotham Asset Management LLC - MarketBeat
Bristol Myers Squibb Company $BMY Stock Position Decreased by Brevan Howard Capital Management LP - MarketBeat
Bank of Nova Scotia Raises Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Raymond James reiterates Market Perform on Bristol-Myers Squibb stock By Investing.com - Investing.com Canada
Bristol Myers Squibb (BMY) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Raymond James reiterates Market Perform on Bristol-Myers Squibb stock - Investing.com
PFE vs BMY: Which Large Oncology Drugmaker Is a Better Pick Now? - TradingView
Capitolis Liquid Global Markets LLC Has $9.29 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
Chevy Chase Trust Holdings LLC Sells 35,963 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
BNP Paribas Decreases Stake in Bristol Myers Squibb Company $BMY - MarketBeat
The top 10 drugs losing US exclusivity in 2026 - Fierce Pharma
Cannell & Spears LLC Has $11.41 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Acquired by Aquatic Capital Management LLC - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Has $29.60 Million Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Ameriprise Financial Inc. Has $1.46 Billion Stock Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
M&T Bank Corp Has $34.43 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
Prudential PLC Acquires 36,159 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY is Independent Franchise Partners LLP's 2nd Largest Position - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by Dodge & Cox - MarketBeat
0.93%
0.37%
자본화:
|
볼륨(24시간):